Abstract:Human islet amyloid polypeptide (hIAPP or amylin) is a causative agent in pancreatic amyloid deposits found in patients with type 2 diabetes. The aggregation of full-length hIAPP(1-37) into small oligomeric species is increasingly believed to be responsible for cell dysfunction and death. However, rat IAPP (rIAPP(1-37)), which differs from hIAPP in only six of 37 residues, loses its aggregation ability to form toxic amyloid species. Atomic details of the effect of sequence on the structure and toxicity between the amyloidogenic, toxic hIAPP peptide and the nonamyloidogenic, nontoxic rIAPP peptide remain unclear. Here, we probe sequence-induced differences in structural stability, conformational dynamics, and driving forces between different hIAPP and rIAPP polymorphic forms from monomer to pentamer using molecular dynamics simulations. Simulations show that hIAPP forms from trimer to pentamer exhibit high structural stability with well-preserved in-register parallel beta-sheet and the U-bend conformation. The hIAPP trimer appears to be a smallest minimal seed in solution. The stabilities of parallel hIAPP oligomers increase with the number of peptides. Conversely, replacement of hIAPP sequence by rIAPP sequence causes a significant loss of favorable interpeptide interactions in all rIAPP oligomers, destabilizing the C-terminal beta-sheet, turn conformation, and overall stability. A less beta-sheet-rich structure and a disturbed U-shaped topology exert a large energy penalty on the self-assemble of the rIAPP peptides into highly ordered, in-register beta-sheet-rich protofibrils and fibrils, which explains the nonamyloidogenic activity of rIAPP. Moreover, the absence of interior water within the U-turn region in the well-packed higher-order hIAPP oligomers, not in the poorly packed rIAPP oligomers, also stabilizes peptide association. This work provides atomic details of the sequence-structure relationship between the amyloidogenic hIAPP and its analogues such as the nonamyloidogenic rIAPP and some mutants, which could help in the development of novel therapeutic agents to block the formation of toxic hIAPP oligomeric species for type 2 diabetes.

Molecular Dynamics Simulation on the Inhibition Mechanism of Peptide-Based Inhibitor of Islet Amyloid Polypeptide (iapp) to Islet Amyloid Polypeptide (Iapp(22-28)) Oligomers

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.

Lipid Interaction And Membrane Perturbation Of Human Islet Amyloid Polypeptide Monomer And Dimer By Molecular Dynamics Simulations

Exploring The Influence Of Carbon Nanoparticles On The Formation Of Beta-Sheet-Rich Oligomers Of Iapp(22-28) Peptide By Molecular Dynamics Simulation

The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide*

Membrane Interactions of Hiapp Monomer and Oligomer with Lipid Membranes by Molecular Dynamics Simulations.

Dynamics of the Conformational Transitions During the Dimerization of an Intrinsically Disordered Peptide: A Case Study on the Human Islet Amyloid Polypeptide Fragment

Molecular Insights into the Oligomerization Dynamics and Conformations of Amyloidogenic and Non-Amyloidogenic Amylin from Discrete Molecular Dynamics Simulations

Hydrophobic/Hydrophilic Ratio of Amphiphilic Helix Mimetics Determines the Effects on Islet Amyloid Polypeptide Aggregation

Molecular Dynamics Simulations Reveal The Inhibitory Mechanism Of Dopamine Against Human Islet Amyloid Polypeptide (Hiapp) Aggregation And Its Destabilization Effect On Hiapp Protofibrils

Structural Polymorphism of Human Islet Amyloid Polypeptide (hiapp) Oligomers Highlights the Importance of Interfacial Residue Interactions.

Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP

Mechanism Study on the Abnormal Accumulation and Deposition of Islet Amyloid Polypeptide by Cold-Spray Ionization Mass Spectrometry.

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

Exploration of Isoquinoline Alkaloids As Potential Inhibitors Against Human Islet Amyloid Polypeptide

Formation of Α-Helical and Β-Sheet Structures in Membrane-Bound Human IAPP Monomer and the Resulting Membrane Deformation.

Mechanism of Inhibition of Human Islet Amyloid Polypeptide-Induced Membrane Damage by a Small Organic Fluorogen

Ph-Dependent Interactions Of Human Islet Amyloid Polypeptide Segments With Insulin Studied By Replica Exchange Molecular Dynamics Simulations

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Computational insights into the inhibition and destabilization of morin on the oligomer of full-length human islet amyloid polypeptide.